Navigation Links
Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
Date:4/14/2008

Newly Designed Blood Glucose Meter Easier to Read and Offers

Next-Generation Benefits that Can Help People Improve Their Diabetes

Management

ABBOTT PARK, Ill., April 14 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced the availability of the FreeStyle Freedom(R) Lite Blood Glucose Monitoring System (http://www.abbottdiabetescare.com/). Offering all of the benefits of Abbott's FreeStyle family of glucose monitoring systems, the newly designed FreeStyle Freedom Lite system provides accurate, reliable results that can help improve diabetes management (http://www.diabetescontrolforlife.com/), which can ultimately lead to better health.

By combining features such as no manual coding, which eliminates one step in the testing process; the world's smallest sample size requirement (0.3 microliter), meaning less pain; and one of the largest displays in an easy-to-read, easy-to-use meter, the FreeStyle Freedom Lite system gives people with diabetes a new option to help simplify their diabetes management routine.

"Diabetes is a unique health condition in that it requires a high degree of self-management," said Lorena Drago, MS, RD, CDN, CDE. "A glucose monitoring device that's easy to use and delivers quick, accurate results can be an invaluable asset in helping a person gain control of their diabetes today, and their long-term health tomorrow."

The FreeStyle Freedom Lite Blood Glucose Monitoring System is available with an instructional video and product brochure in both English and Spanish.

About Abbott Diabetes Care

Abbott Diabetes Care, based in Alameda, Calif., is a leader in developing, manufacturing and marketing glucose monitoring systems designed to help people better manage their diabetes. Abbott Diabetes Care is committed to developing products that reduce the discomfort and inconvenience of glucose monitoring and introducing systems that are easier to use, require smaller samples and provide faster results.

Abbott Diabetes Care markets several leading-edge glucose monitoring systems and test strips in the United States for use in both home and hospital settings; leading brands include FreeStyle(R) Lite, FreeStyle Freedom(R) Lite, FreeStyle Freedom(TM), FreeStyle Flash(R) and Precision Xtra(TM), as well as its newest diabetes management tool, FreeStyle Navigator(R) Continuous Glucose Monitoring System. Additional information about Abbott Diabetes Care may be found at http://www.abbottdiabetescare.com.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 68,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 19, 2017 , ... Attorney Robert “RC” Pate , founder of The ... the Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric ... firsthand the effect of the critical funding gap for research into pediatric cancer research. ...
(Date:1/19/2017)... ... ... Connecticut Dermatology Group (CDG) is proud and excited to welcome back to the ... brings an extensive background in cutting-edge dermatology care and research to Connecticut’s largest ... Kim to the CDG team” said President and Managing Partner Dr. Steven A. Kolenik ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons from ... in breast surgery. Covering topics from cosmetic breast augmentation to breast ...
(Date:1/18/2017)... ... ... From a health perspective, 2017 will clearly be the Year of the Gut. ... health and general physical well-being. The New York Times suggested a “ Gut Makeover ... Charlottesville restaurant, good gut health is clearly on the menu. Threepenny Cafe ...
(Date:1/18/2017)... ... January 18, 2017 , ... The V Foundation for ... V, its official endurance training and fundraising team, to compete in the Boston Marathon ... those inspired to finish the world’s oldest annual marathon to join Team V and ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017  Aprima Medical ... records (EHR), practice management (PM) and revenue cycle ... the acquisition of a former reseller Healthcare Data ... of the agreement, Aprima will assume full support ... in 125 medical practices across 15 states. Financial ...
(Date:1/18/2017)... 18, 2017 The Philadelphia Pediatric Medical Device Consortium ... devices for children. The Consortium chose those companies ... of $50,000 each. The devices under development are ... a hand-operated rapid blood delivery system for emergency situations and ... ...
(Date:1/18/2017)... , Jan. 18, 2017   Regenicin, Inc. ... biotechnology company specializing in the development and commercialization of ... tissues and organs, recently reported the Company,s operating results ... 2017. As the Company described in its ... a year of substantial accomplishments. The Company,s contract laboratory ...
Breaking Medicine Technology: